PR Newswire: news distribution, targeting and monitoring
2014

Nutraceutical Reports Fiscal 2009 Year End Results

Share with Twitter Share with LinkedIn

PARK CITY, Utah, Dec. 10 /PRNewswire-FirstCall/ -- Nutraceutical International Corporation (Nasdaq: NUTR) today reported results for the fiscal 2009 fourth quarter and year ended September 30, 2009. Net sales for the fiscal 2009 fourth quarter were $41.4 million compared to $40.9 million for the same quarter of fiscal 2008. For the fourth quarter of fiscal 2009, net income was $3.2 million, or $0.29 diluted earnings per share, compared to net income of $1.5 million, or $0.14 diluted earnings per share, for the same quarter of fiscal 2008. Net income for the fourth quarter of fiscal 2008 included a non-cash goodwill impairment charge of $1.8 million after tax, or $0.17 per diluted share.

Net sales for the fiscal year ended September 30, 2009 were $162.3 million compared to $166.9 million for the same period in fiscal 2008. During the second quarter of fiscal 2009, the Company recorded a non-cash goodwill impairment charge of $37.5 million ($27.3 million after tax, or $2.52 per diluted share for the fiscal year ended September 30, 2009) resulting in a net loss of $(14.0) million, or $(1.29) per diluted share, for the fiscal year ended September 30, 2009, compared to net income of $11.9 million (including the $1.8 million goodwill impairment charge), or $1.07 per diluted share (including the goodwill impairment charge of $0.16 per share), for the same period of fiscal 2008.

Operating cash flow for the fiscal year ended September 30, 2009 was $27.8 million compared to $20.3 million for the same period of fiscal 2008. This operating cash flow was primarily used to invest $9.2 million in purchases of property and equipment, $4.6 million in the acquisition of a branded natural product business, $4.4 million in repurchases of common stock and $9.5 million to repay net borrowings on the Company's revolving credit facility.

Bill Gay, chairman and chief executive officer, commented, "Health and natural food store sales improved in the fourth quarter despite the ongoing economic uncertainties and we are hopeful that this strength will continue. Net income for the fourth quarter remained solid and cash flows increased as a result of inventory reductions. Gross margins declined slightly due to increased raw material prices and manufacturing overhead costs related to inventory decreases. Selling, general and administrative expense improvements throughout the fiscal year offset gross margin decreases. Our core customers are regaining confidence in their businesses and we remain optimistic about the coming year. Ongoing sales programs and promotions appear to be benefiting stores, consumers and our Company. It is encouraging that the public market has responded favorably to the Company's recent addition to the Russell 2000 stock index and we believe our financial strength and position as a value based stock will bring awareness to new investors this coming year."

Mr. Gay continued, "We believe gross margins will improve in fiscal 2010. We also expect acquisitions to contribute to sales, profitability, EBITDA and cash flow during fiscal 2010. The October 9, 2009 acquisition of the Lifetime® brand strengthens our product offerings, especially for those consumers who prefer liquid and powder delivery forms of nutritional supplements."

ABOUT NUTRACEUTICAL

We are an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Our core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. We believe that the consolidation and integration of these acquired businesses provides ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.

We manufacture and sell nutritional supplements and other natural products under numerous brands including Solaray®, VegLife®, KAL®, Nature's Life®, Sunny Green®, Action Labs®, Natural Balance®, NaturalMax®, bioAllers®, Herbs for Kids(TM), Natra-Bio®, NaturalCare®, Zand®, Health from the Sun®, Life-flo®, Larenim®, Living Flower Essences®, Pioneer®, Thompson®, Natural Sport®, Supplement Training Systems®, Premier One®, Montana Big Sky(TM), ActiPet®, FunFresh Foods(TM), Dowd & Rogers(TM), CompliMed®, AllVia(TM), Oakmont Labs®, Healthway®, Body Gold®, Sayge®, Monarch Nutraceuticals(TM) and Great Basin Botanicals(TM). Under the name Woodland Publishing(TM), we publish, print and market a line of books and booklets to, among others, book distributors, national retail bookstores and health and natural food stores. We also distribute branded products of certain third parties.

We own neighborhood natural food markets, which operate under the trade names The Real Food Company(TM), Thom's Natural Foods(TM) and Cornucopia Community Market(TM). We also own health food stores, which operate under the trade names Fresh Vitamins(TM) and Granola's(TM).

We manufacture and/or distribute one of the broadest branded product lines in the industry with over 4,000 SKUs, including over 700 SKUs sold internationally. We believe that as a result of our emphasis on innovation, quality, loyalty, education and customer service, our brands are widely recognized in health and natural food stores and among their customers.

This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward-looking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) slow or negative growth in the nutritional supplement industry or the healthy foods channel, (ii) adverse publicity or negative consumer perception regarding nutritional supplements, (iii) unavailability of desirable acquisitions or inability to complete them, (iv) changes in or new government regulations or increased enforcement of the same, (v) litigation and claims, including product liability, intellectual property and other types, (vi) insurance coverage issues, (vii) increased competition, (viii) increased costs, including from increased energy prices, (ix) the loss of key personnel or the inability to manage our operations efficiently, (x) disruptions from acquisitions including the loss of customers, (xi) issues with obtaining raw materials of adequate quality or quantity, or increases in the cost, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) changes in general worldwide economic or political conditions, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control. Copies of our SEC reports are available upon request from our investor relations department or may be obtained at the SEC's website (www.sec.gov).

© 2009 Nutraceutical Corporation. All rights reserved.


                 NUTRACEUTICAL INTERNATIONAL CORPORATION
                  CONDENSED CONSOLIDATED BALANCE SHEETS
                    (unaudited; dollars in thousands)

                                          September 30,      September 30,
                                          -------------      -------------
                                              2009               2008
Assets
     Current assets, net                     $50,582             $55,577
     Property, plant and equipment, net       55,584              52,356
     Goodwill                                  1,177              37,632
     Other non-current assets, net            26,617              16,099
                                              ------              ------
                                            $133,960            $161,664
                                            --------            --------

Liabilities and Stockholders' Equity
     Current liabilities                     $18,138             $19,239
     Long-term liabilities                    20,184              28,965
     Stockholders' equity                     95,638             113,460
                                              ------             -------
                                            $133,960            $161,664
                                            --------            --------




                 NUTRACEUTICAL INTERNATIONAL CORPORATION
              CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
           (unaudited; dollars in thousands, except per share data)

                              Three months ended      Twelve months ended
                                 September 30,           September 30,
                              ------------------      -------------------
                                2009        2008        2009       2008

Net sales                     $41,354     $40,899    $162,346    $166,885
Cost of sales                  20,173      18,914      77,137      76,106
                               ------      ------      ------      ------
    Gross profit               21,181      21,985      85,209      90,779
Operating expenses
    Selling, general and
     administrative            15,610      16,434      62,195      66,973
    Amortization of
     intangible assets            217         179         697         701
    Impairment of goodwill
     and intangible asset           -       2,875      37,519       2,875
                                  ---       -----      ------       -----
Income (loss) from
 operations                     5,354       2,497     (15,202)     20,230
Interest and other
 (income) expense, net            153         262       1,104       1,270
                                  ---         ---       -----       -----
Income (loss) before
 provision (benefit) for
 income taxes                   5,201       2,235     (16,306)     18,960
Provision (benefit) for
 income taxes                   2,010         708      (2,269)      7,017
                                -----         ---      ------       -----

Net income (loss)              $3,191      $1,527    $(14,037)    $11,943
                               ------      ------    --------     -------


Net income (loss) per
 common share
    Basic                       $0.30       $0.14      $(1.29)      $1.09
    Diluted                      0.29        0.14       (1.29)       1.07

Weighted average common
 shares outstanding
    Basic                  10,743,463  10,846,018  10,841,383  10,993,505
    Diluted                10,827,759  10,966,785  10,841,383  11,127,634




                  NUTRACEUTICAL INTERNATIONAL CORPORATION
                         ADJUSTED EBITDA SCHEDULE
                    (unaudited; dollars in thousands)


                              Three months ended      Twelve months ended
                                 September 30,           September 30,
                              ------------------      -------------------
                                2009        2008        2009       2008

Net income (loss)              $3,191      $1,527   $(14,037)     $11,943
Provision (benefit)
 for income taxes               2,010         708     (2,269)       7,017
Interest and other
 (income) expense, net (1)        153         262      1,104        1,270
Depreciation and
 amortization                   1,672       1,603      6,631        5,859
Impairment of goodwill
 and intangible asset (2)           -       2,875     37,519        2,875
                                  ---       -----     ------        -----

Adjusted EBITDA                $7,026      $6,975    $28,948      $28,964
                               ------      ------    -------      -------

(1) Includes amortization of deferred financing fees.
(2) For the twelve months ended September 30, 2009, a non-cash goodwill
    impairment charge of $37,519 was recorded related to our branded and
    natural food markets reporting units.  For the three months and twelve
    months ended September 30, 2008, a non-cash goodwill impairment charge
    of $2,875 was recorded related to our health food stores reporting
    unit.



SOURCE Nutraceutical International Corporation



Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release